Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
- 15 October 2011
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 25 (20), 2147-2157
- https://doi.org/10.1101/gad.17546311
Abstract
The aberrant expression of an oncogenic ETS transcription factor is implicated in the progression of the majority of prostate cancers, 40% of melanomas, and most cases of gastrointestinal stromal tumor and Ewing's sarcoma. Chromosomal rearrangements in prostate cancer result in overexpression of any one of four ETS transcription factors. How these four oncogenic ETS genes differ from the numerous other ETS genes expressed in normal prostate and contribute to tumor progression is not understood. We report that these oncogenic ETS proteins, but not other ETS factors, enhance prostate cell migration. Genome-wide binding analysis matched this specific biological function to occupancy of a unique set of genomic sites highlighted by the presence of ETS- and AP-1-binding sequences. ETS/AP-1-binding sequences are prototypical RAS-responsive elements, but oncogenic ETS proteins activated a RAS/MAPK transcriptional program in the absence of MAPK activation. Thus, overexpression of oncogenic ETS proteins can replace RAS/MAPK pathway activation in prostate cells. The genomic description of this ETS/AP-1-regulated, RAS-responsive, gene expression program provides a resource for understanding the role of these ETS factors in both an oncogenic setting and the developmental processes where these genes normally function.Keywords
This publication has 57 references indexed in Scilit:
- Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progressionThe Prostate, 2011
- ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumoursNature, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Genome-wide analysis of ETS-family DNA-binding in vitro and in vivoThe EMBO Journal, 2010
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer ProgressionCancer Cell, 2010
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in CancerCell, 2009
- The role of the ETS factor erg in zebrafish vasculogenesisMechanisms of Development, 2009
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisNature Genetics, 2009
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateNature Genetics, 2009
- Mutations of the BRAF gene in human cancerNature, 2002